Sarena Santos
|
 |
That if the government gets involved, they'll ramelteon be worse off." Last month, prescription drug prices canada the Food and Drug Administration stepped up its watch by asking consumers to help watch for false or misleading drug ads. Among factors driving the drop, he says, ramelteon are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. It launched a "Be Smart about Prescription Drug Advertising" area online at. Two recent reports say drugmakers cut Rx ad spending in the first six months of this year. Some major brands, such as Pfizer's Lipitor, have revamped ads under government sleeping pills pressure. online prescription drugs without prescription Pharmaceutical ad spending they count on to exceed $5 billion a year is losing its potency. TNS Media Intelligence puts the drop at 3.9% to $2.4 insomnia medicine billion. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, spent $75million on ads in the first quarter of 2008 vs. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. Second-quarter sleep medications spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. (c) 2008 USA TODAY, a division of Gannett Co. "The pharmaceutical companies perceive sleep meds the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. The reports follow a well-publicized Harvard Medical School study that sleep medications found consumer ads had little effect on prescription drug sales. And it comes as they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street. "Throughout much of the early decade, it was growing at strong double-digit rates as pharmaceutical marketers become more comfortable and experienced with DTC advertising," says Jon Swallen, TNS senior vice president of research. The site encourages consumers to keep an eye out for false or misleading ads and provides a link to report violators. Results sho that direct-to-consumer (DTC) ads "probably aren't as effective as widely perceived," says Michael Law, lead That bodes ill for the magazines, newspapers and radio and TV outlets for which the ads have been a prescription for profits. Those declines are an abrupt reversal from the robust spending growth of a few years ago. Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). By Gwenora Petrecca NEW YORK -- This could make media owners sick. $175million in that quarter in 2007. Magazines and radio stations have seen the most drug ad decline. A service of YellowBrix, Inc.. Researchers focused on ads for three drugs. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Harv Forester and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year.
|